Podcast Episodes
Back to Search
Managing Critical Risks in Early-Stage Medtech: Interview with Instylla CEO Amarpreet Sawhney
In this episode of Medsider Radio, we had an insightful chat with Amarpreet Sawhney, inventor, serial entrepreneur, and CEO of a few startups, includ…
1 year, 10 months ago
Build for the User, Not the Spec Sheet: Interview with Phagenesis CEO Reinhard Krickl
In this episode of Medsider Radio, we had an engaging chat with Reinhard Krickl, CEO of Phagenesis, a startup commercializing a neurostimulation syst…
1 year, 10 months ago
A Stage-Appropriate Framework for Startups: Interview with Cherish CEO Sumit Nagpal
In this episode of Medsider Radio, we had an interesting chat with Sumit Nagpal, founder and CEO of Cherish Health, a company developing radar-based …
1 year, 11 months ago
Forging Win-Win Collaborations in Healthcare: Interview with Reimagine Care CEO Dan Nardi
In this episode of Medsider Radio, we had an insightful chat with Dan Nardi, CEO of Reimagine Care, a startup that integrates clinical oncology exper…
1 year, 11 months ago
How to Build a Community of Investors: Interview with Pirouette Medical CEO Conor Cullinane
In this episode of Medsider Radio, we had a fun chat with Conor Cullinane, co-founder and CEO of Pirouette Medical. The company, founded by three roc…
1 year, 11 months ago
A Physician's Guide to Turning Ideas into Reality: Interview With Canary Medical CEO Dr. Bill Hunter
In this episode of Medsider Radio, we had an insightful chat with Dr. Bill Hunter, CEO of Canary Medical. The company is developing smart, implantab…
2 years ago
Silicon Valley Approach to Medtech: Interview with Oncoustics CEO Beth Rogozinski
In this episode of Medsider Radio, we had a compelling chat with Beth Rogozinski, CEO of Oncoustics. The company uses advanced AI to analyze ultrasou…
2 years ago
Proof Before Funding: Interview with VenoStent CEO and COO, Tim Boire and Geoffrey Lucks
In this episode of Medsider Radio, we had an insightful discussion with Timothy Boire and Geoffrey Lucks, co-founders of VenoStent. The company is de…
2 years ago
A Roadmap for Proving Clinical Efficacy and Economic Value: Interview with Mainstay Medical CEO Jason Hannon
In this episode of Medsider Radio, we sat down with Jason Hannon, President and CEO of Mainstay Medical, where he and his team are commercializing Re…
2 years ago
Overcoming Skepticism When Commercializing Novel Therapies: Interview with Taopatch USA CEO Dmitri Leonov
In this episode of Medsider Radio, we had a fascinating chat with Dmitri Leonov, co-founder and CEO of Taopatch USA. The company is commercializing a…
2 years, 1 month ago